These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 17485189

  • 1. In vitro evaluation of alternative oral contrast agents for MRI of the gastrointestinal tract.
    Babos M, Schwarcz A, Randhawa MS, Marton B, Kardos L, Palkó A.
    Eur J Radiol; 2008 Jan; 65(1):133-9. PubMed ID: 17485189
    [Abstract] [Full Text] [Related]

  • 2. In vivo biochemical 7.0 Tesla magnetic resonance: preliminary results of dGEMRIC, zonal T2, and T2* mapping of articular cartilage.
    Welsch GH, Mamisch TC, Hughes T, Zilkens C, Quirbach S, Scheffler K, Kraff O, Schweitzer ME, Szomolanyi P, Trattnig S.
    Invest Radiol; 2008 Sep; 43(9):619-26. PubMed ID: 18708855
    [Abstract] [Full Text] [Related]

  • 3. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
    Kubota T, Yamada K, Kizu O, Hirota T, Ito H, Ishihara K, Nishimura T.
    J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
    [Abstract] [Full Text] [Related]

  • 4. Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid.
    Brody JM, Schafer L, Tung GA, Breuer J, Shamsi K.
    J Magn Reson Imaging; 2005 Apr; 21(4):391-7. PubMed ID: 15778951
    [Abstract] [Full Text] [Related]

  • 5. [Optimization of dosage and exam technique in the use of oral contrast media in magnetic resonance].
    Broglia L, Tortora A, Maccioni F, Arpesani R, Marcelli G, Ascarelli A, Rossi P.
    Radiol Med; 1999 May; 97(5):365-70. PubMed ID: 10432968
    [Abstract] [Full Text] [Related]

  • 6. Quantitative evaluation of the relaxivity effects of iodine on GD-DTPA enhanced MR arthrography.
    Ganguly A, Gold GE, Butts Pauly K, Mayer D, Moseley MM, Pelc NJ, Fahrig R.
    J Magn Reson Imaging; 2007 Jun; 25(6):1219-25. PubMed ID: 17520728
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Equilibrium signal intensity mapping, an MRI method for fast mapping of longitudinal relaxation rates and for image enhancement.
    Surányi P, Kiss P, Ruzsics B, Brott BC, Simor T, Elgavish GA.
    Magn Reson Imaging; 2007 Jun; 25(5):641-51. PubMed ID: 17540275
    [Abstract] [Full Text] [Related]

  • 9. [Diagnostic evaluation of chronic inflammatory intestinal diseases in children and adolescents: MRI with true-FISP as new gold standard?].
    Hohl C, Haage P, Krombach GA, Schmidt T, Ahaus M, Günther RW, Staatz G.
    Rofo; 2005 Jun; 177(6):856-63. PubMed ID: 15902636
    [Abstract] [Full Text] [Related]

  • 10. Contrast-enhanced multi-shot echo-planar FLAIR in the depiction of metastatic tumors of the brain: comparison with contrast-enhanced spin-echo T1-weighted imaging.
    Tomura N, Narita K, Takahashi S, Otani T, Sakuma I, Yasuda K, Nishii T, Watarai J.
    Acta Radiol; 2007 Nov; 48(9):1032-7. PubMed ID: 17957522
    [Abstract] [Full Text] [Related]

  • 11. Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.
    Nassenstein K, Breuckmann F, Hunold P, Barkhausen J, Schlosser T.
    Acta Radiol; 2009 May; 50(4):406-11. PubMed ID: 19308763
    [Abstract] [Full Text] [Related]

  • 12. MR of the small bowel with a biphasic oral contrast agent (polyethylene glycol): technical aspects and findings in patients affected by Crohn's disease.
    Laghi A, Paolantonio P, Iafrate F, Borrelli O, Dito L, Tomei E, Cucchiara S, Passariello R.
    Radiol Med; 2003 May; 106(1-2):18-27. PubMed ID: 12951547
    [Abstract] [Full Text] [Related]

  • 13. Spin-lock MRI with amplitude- and phase-modulated adiabatic waveforms: an MR simulation study.
    Taheri S, Sood R.
    Magn Reson Imaging; 2006 Jan; 24(1):51-9. PubMed ID: 16410178
    [Abstract] [Full Text] [Related]

  • 14. Contrast agents: magnetic resonance.
    Burtea C, Laurent S, Vander Elst L, Muller RN.
    Handb Exp Pharmacol; 2008 Jan; (185 Pt 1):135-65. PubMed ID: 18626802
    [Abstract] [Full Text] [Related]

  • 15. Diffusion generated T1 and T2 contrast.
    Kaufmann I, Seiberlich N, Haase A, Jakob P.
    J Magn Reson; 2008 May; 192(1):139-50. PubMed ID: 18316216
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of spectral presaturation attenuated inversion-recovery fat-suppressed T2-weighted MR imaging in active inflammatory bowel disease.
    Udayasankar UK, Martin D, Lauenstein T, Rutherford R, Galloway J, Tudorascu D, Sitaraman SV.
    J Magn Reson Imaging; 2008 Nov; 28(5):1133-40. PubMed ID: 18972354
    [Abstract] [Full Text] [Related]

  • 18. Benign prostatic hyperplasia: evaluation of T1, T2, and microvascular characteristics with T1-weighted dynamic contrast-enhanced MRI.
    Kershaw LE, Hutchinson CE, Buckley DL.
    J Magn Reson Imaging; 2009 Mar; 29(3):641-8. PubMed ID: 19243046
    [Abstract] [Full Text] [Related]

  • 19. Comparison of Gd-DTPA-induced signal enhancements in rat brain C6 glioma among different pulse sequences in 3-Tesla magnetic resonance imaging.
    Sato H, Enmi J, Teramoto N, Hayashi T, Yamamoto A, Tsuji T, Naito H, Iida H.
    Acta Radiol; 2008 Mar; 49(2):172-9. PubMed ID: 18300142
    [Abstract] [Full Text] [Related]

  • 20. Gadolinium-enhancing or active T2 magnetic resonance imaging lesions in multiple sclerosis clinical trials?
    Bonzano L, Roccatagliata L, Mancardi GL, Sormani MP.
    Mult Scler; 2009 Sep; 15(9):1043-7. PubMed ID: 19570818
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.